European Pharmaceutical Review

MARCH 14, 2023

This is due to the regulatory requirements imposed on parallel imported medicinal products in various Member States, the fulfilment of which often requires repackaging. Repackaging a medicinal product… means that the trademark is reapplied by an entity other than the trademark proprietor.”

Packaging 98

Packaging Generic Medicine Labelling Pharmaceutical Companies 98

pharmaphorum

JANUARY 30, 2023

These include allowing the exceptional supply of certain medicines that may not be authorised in a particular Member State or granting full or partial exemptions to certain labelling and packaging requirements to address severe problems in respect of the availability of some medicines.”

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

pharmaphorum

MAY 26, 2022

Certain groups of individuals may then not trust that the medicines have been produced with them in mind and may be highly sceptical of the resulting evidence base and prescribing label of medicines. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143